With $30 million in funding from the Coalition for Epidemic Preparedness Innovations (CEPI), Merck & Co. | The project, which involves Merck, SK Biosciences, Hilleman Laboratories and CDMO IDT ...

Merck & Co., Inc. (NYSE:MRK) is included among Dividend Contenders List: Top 20 Stocks. Reuters reported that Merck & Co., ...

NEW YORK CITY, NY / ACCESS Newswire / February 3, 2025 / The first participants have been vaccinated with an investigational Ebola Sudan vaccine candidate provided by IAVI, a nonprofit scientific ...

The collaboration aims to change the manufacturing process with the goal of increasing yield and the vaccine's shelf life, allowing it to be stored in regular refrigerators for several months. ・Merck ...

Jan 21 (Reuters) - Merck & Co unit MSD and the Coalition for Epidemic Preparedness Innovations said on Wednesday they have partnered on a $30 million program to develop an updated version of the ...

An experimental Ebola vaccine will be tested on humans for the first time next week in a collaboration between the U.S. government and pharmaceutical company GlaxoSmithKline. There are other drugs on ...

The vaccine, called rVSV-ZEBOV, was studied in a trial involving 11,841 people in Guinea during 2015. Among the 5,837 people who received the vaccine, no Ebola cases were recorded 10 days or more ...

“Through this CEPI-supported partnership, SK bioscience will continue to play a critical role in improving Zaire ebolavirus ...

The Democratic Republic of the Congo (DRC) has declared a new Ebola outbreak in Kasai Province. It's caused by the most severe strain: Zaire Ebola virus. Filoviruses are among the globe's most ...

Johns Hopkins Bloomberg School of Public Health researchers say that major disruptions in the health care systems in West Africa caused by the Ebola crisis have led to significant decreases in ...

Pioneering biostatistician and infectious disease expert Dr. Elizabeth Halloran recently transitioned to emerita after a ...

April 1 -- MONDAY, March 31 (HealthDay News) -- Researchers have successfully tested several Ebola vaccines in monkeys and are now working to create the first human vaccine for one of the world's ...